Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM | NSE
2,070.40
INR18.60
0.91%
JBCHEPHARM | NSE
About J. B. Chemicals & Pharmaceuticals Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
05/03/2026
Close
2,070.40
Open
2,066.00
High
2,075.40
Low
2,048.20
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations herbal remedies and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine Ranitidine and Metronidazole. The company also provides contract manufacturing services for tablets lozenges injectables gels creams ointments liquid herbal syrups and capsules; and soft-centered powder medicated and herbal lozenges as well as various pharmaceutical dosage forms. In addition it offers a range of contrast media products including x-ray magnetic resonance imaging (MRI) and ultrasound scanners. Further the company provides its services in gastroenterology hypertension diabetes dermatology nephrology wound care anti-infectives and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai India.
View LessJBCHEPHARM | NSE
Risk
25.4
Sharpe
1.01
Luna's Score
70/100
Recommendation
Buy
Luna says (JBCHEPHARM | NSE)
What's Working
Strength based on increasing price with high volume
Low 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Midcap (2B - 10B USD)
Rich in Valuation (Price to Book > 8)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
18.4%1 month
25.4%3 months
22.3%6 months
21.0%Returns
Fundamental Ratios
PE
51.20
Fwd. PE
21.69
Price to book
10.01
Debt to equity
0.13
Debt to assets
0.09
Ent. to EBITDA
29.70
Ent. to rev.
8.20
PEG
-
Other Fundamentals
EBITDA
9.34B
MarketCap
321.56B
MarketCap(USD)
3.50B
Div. yield
0.72
Op. margin
23.85
Erngs. growth
23.00
Rev. growth
12.10
Ret. on equity
20.45
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
145.70
Range1M
275.50
Range3M
357.20
Volumes: Market Activity
Rel. volume
1.13
Price X volume
782.38M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 29.70 | 24.85 | Par |
| Ent. to Revenue | 8.20 | 11.40 | Cheaper |
| PE Ratio | 51.20 | 51.36 | Par |
| Price to Book | 10.01 | 6.83 | Expensive |
| Dividend Yield | 0.72 | 0.52 | Leader |
| Std. Deviation (3M) | 22.34 | 42.17 | Lower Risk |
| Debt to Equity | 0.13 | 0.35 | Cheaper |
| Debt to Assets | 0.09 | 0.17 | Cheaper |
| Market Cap | 321.56B | 290.82B | Par |
